Ethinyloestradiol 30 mcg with desogestrel 150 mcg (Marvelon): Discontinued

Marvelon is a combined oral contraceptive. The supplier – Merck Sharp & Dohme (MSD) – have discontinued the supply of this contraceptive.

We understand that stock for Marvelon is currently depleted and there will be no further orders coming into New Zealand.

Information for people taking Marvelon

Your health professional will provide you with advice on what alternative might be best for you.  

Information for prescribers

We encourage you to identify any patients taking Marvelon and support them moving to a different funded option. 

Mercilon (ethinyloestradiol 20 mcg with desogestrel 150 mcg) will still be available and may be a suitable option for patients.

BPAC provides guidance for health professionals about other funded contraceptive options.

Information for pharmacists

We understand that stock for Marvelon is currently depleted and there will be no further orders coming into New Zealand.

PHARMAC will notify the delisting date soon.

If you have questions about the availability of Marvelon, contact MSD on 0800 500 673(external link)